Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Follow-up and Booster of DEN Vaccine F17 in Thai Children
NCT01843621Phase 2Completed
- Sponsor
- U.S. Army Medical Research and Development Command
- Start
- Feb 2005
- Primary completion
- Feb 2005
- Modality
- Live Attenuated Vaccines
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of T-DEN vaccine in dengue fever, sponsored by U.S. Army Medical Research and Development Command. Primary endpoints: Percentage of Subjects With Seropositivity Rates for Antibodies to DEN-1 - DEN-4 at Year 3 and Geometric Mean Titers (GMTs) on All Subjects for Antibodies to DEN-1 - DEN-4 at Year 3. Started Feb 2005; status: completed.
02
Drugs
T-DEN vaccine
03
Conditions
dengue fever
Beyond the preview
Go deeper on NCT01843621.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01843621.